Please wait while the formulary information is being retrieved.
CALCITRIOL (CALCITRIOL)
- Hypocalcemia
- Hyperparathyroidism secondary to chronic renal failure
- Hypocalcemia from ESRD with dialysis
- Hypoparathyroidism
- Hypophosphatemia
- Renal osteodystrophy
1 mcg/mL oral solution
- 1 milliliter (1 mcg) by oral route once daily
0.25 mcg capsule
- 1 capsule (0.25 mcg) by oral route once daily
0.5 mcg capsule
- 1 capsule (0.5 mcg) by oral route once daily
1 mcg/mL oral solution
- 1 milliliter (1 mcg) by oral route once daily
0.25 mcg capsule
- 1 capsule (0.25 mcg) by oral route once daily
0.5 mcg capsule
- 1 capsule (0.5 mcg) by oral route once daily
Hyperparathyroidism secondary to chronic renal failure
- 1 capsule (0.25 mcg) by oral route once daily
- 0.25 milliliter (0.25 mcg) by oral route once daily
- 0.5 milliliter (0.5 mcg) by oral route once daily
- 1 capsule (0.5 mcg) by oral route once daily
- 2 capsules (0.5 mcg) by oral route once daily
Hypocalcemia
- 0.5 milliliter (0.5 mcg) by oral route once daily
- 1 capsule (0.5 mcg) by oral route once daily
- 2 capsules (0.5 mcg) by oral route once daily
- 1 milliliter (1 mcg) by oral route once daily
- 2 capsules (1 mcg) by oral route once daily
Hypocalcemia from ESRD with dialysis
- 0.5 milliliter (0.5 mcg) by oral route once daily
- 1 capsule (0.5 mcg) by oral route once daily
- 2 capsules (0.5 mcg) by oral route once daily
- 6 capsules (3 mcg) by oral route once daily
- 3 milliliters (3 mcg) by oral route once daily
Hypoparathyroidism
- 0.5 milliliter (0.5 mcg) by oral route once daily
- 1 capsule (0.5 mcg) by oral route once daily
- 2 capsules (0.5 mcg) by oral route once daily
- 2 milliliters (2 mcg) by oral route once daily
- 4 capsules (2 mcg) by oral route once daily
Hypophosphatemia
- 2 milliliters (2 mcg) by oral route once daily
- 4 capsules (2 mcg) by oral route once daily
Renal osteodystrophy
- 1 capsule (0.25 mcg) by oral route every other day
- 0.25 milliliter (0.25 mcg) by oral route every other day
- 6 capsules (3 mcg) by oral route once daily
- 3 milliliters (3 mcg) by oral route once daily
Rickets
- 4 capsules (1 mcg) by oral route once daily
- 1 milliliter (1 mcg) by oral route once daily
- 2 capsules (1 mcg) by oral route once daily
X-linked hypophosphatemic osteomalacia
- 2 milliliters (2 mcg) by oral route once daily
- 4 capsules (2 mcg) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Hypervitaminosis D
Contraindicated
- Arteriosclerosis obliterans
- Hypercalcemia
- Hyperphosphatemia
- Kidney stone
Severe
Moderate
- Kidney disease with reduction in GFR
- Sarcoidosis
CALCITRIOL (CALCITRIOL)
- Hypocalcemia
- Hyperparathyroidism secondary to chronic renal failure
- Hypocalcemia from ESRD with dialysis
- Hypoparathyroidism
- Hypophosphatemia
- Renal osteodystrophy
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute pancreatitis
- Anaphylaxis
- Bone pain
- Cardiac arrhythmia
- Conjunctivitis
- Dehydration
- Drug-induced psychosis
- Erythema multiforme
- Fever
- Hypercalcemia
- Hypersensitivity drug reaction
- Hypertension
- Urinary tract infection
Less Severe
- Abdominal pain with cramps
- Anorexia
- Constipation
- Drowsy
- Dysgeusia
- General weakness
- Headache disorder
- Hypercholesterolemia
- Libido changes
- Myalgias
- Nausea
- Nocturia
- Photophobia
- Polydipsia
- Polyuria
- Proteinuria
- Pruritus of skin
- Rhinorrhea
- Vomiting
- Weight loss
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Calcitriol
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Calcitriol
Use not recommended.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Use not recommended. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hyperparathyroidism secondary to chronic renal failure | |
| N25.81 | Secondary hyperparathyroidism of renal origin |
| Hypocalcemia | |
| E83.51 | Hypocalcemia |
| P71.0 | Cow's milk hypocalcemia in newborn |
| P71.1 | Other neonatal hypocalcemia |
| Hypocalcemia from ESRD with dialysis | |
| E83.51 | Hypocalcemia |
| Hypoparathyroidism | |
| E20 | Hypoparathyroidism |
| E20.0 | Idiopathic hypoparathyroidism |
| E20.1 | Pseudohypoparathyroidism |
| E20.8 | Other hypoparathyroidism |
| E20.9 | Hypoparathyroidism, unspecified |
| E89.2 | Postprocedural hypoparathyroidism |
| Hypophosphatemia | |
| E83.31 | Familial hypophosphatemia |
| Renal osteodystrophy | |
| N25.0 | Renal osteodystrophy |
| 0-9 | A-Z |
|---|---|
| E20 | Hypoparathyroidism |
| E20.0 | Idiopathic hypoparathyroidism |
| E20.1 | Pseudohypoparathyroidism |
| E20.8 | Other hypoparathyroidism |
| E20.9 | Hypoparathyroidism, unspecified |
| E83.31 | Familial hypophosphatemia |
| E83.51 | Hypocalcemia |
| E83.51 | Hypocalcemia |
| E89.2 | Postprocedural hypoparathyroidism |
| N25.0 | Renal osteodystrophy |
| N25.81 | Secondary hyperparathyroidism of renal origin |
| P71.0 | Cow's milk hypocalcemia in newborn |
| P71.1 | Other neonatal hypocalcemia |
Formulary Reference Tool